Skip to content

OABI

OmniAb, Inc.

NASDAQ · Healthcare · Biotechnology · US

$5.18
+0.58%
Ask drillr

Next report

Analyst consensus

Next report date
Mar 24, 2027
EPS estimate
-$0.12
Revenue estimate
$5.2M

Latest reported

Last report date
Oct 30, 2026
EPS actual
-$0.12
EPS estimate
-$0.13
Revenue actual
$4.0M
Revenue estimate
$3.5M

Track record

Trailing twelve quarters

EPS beats (12Q)
6
EPS misses (12Q)
5
EPS in line (12Q)
1
Avg surprise (4Q)
+16.6%
Revenue beats (12Q)
6

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$9.67
PT range
$6.00 – $12
Analysts
3
3 Buy0 Hold0 Sell
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Oct 30, 2026-$0.13-$0.12Beat 5.62%$4.0M
Aug 6, 2026-$0.12-$0.05Beat 58.33%$13.4M
May 7, 2026-$0.10-$0.06Beat 40.00%$14.4M
Mar 4, 2026-$0.08-$0.11Miss -37.50%$8.4M
Nov 4, 2025-$0.14-$0.14Miss -2.94%$2.2M
Aug 6, 2025-$0.14-$0.15Miss -7.14%$3.9M
May 8, 2025-$0.17-$0.17In line$4.2M
Mar 18, 2025-$0.13-$0.12Beat 7.69%$10.8M
Aug 8, 2024-$0.18-$0.13Beat 27.78%$7.6M
May 9, 2024-$0.17-$0.19Miss -11.76%$3.8M
Mar 20, 2024-$0.17-$0.14Beat 17.65%$4.8M
Nov 9, 2023-$0.14-$0.16Miss -14.29%$5.5M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 24, 2027